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The somatoform disorders are charac-
terised by the presence of physical symp-
toms in the absence of a diagnosable
medical illness to account fully for them.
The symptoms are presumed to be psy-
chologically based, outside the patient’s
conscious control, and should be severe
enough to cause significant distress, or
impair interpersonal, social and occupa-
tional functioning. Patients presenting
with somatoform symptoms are seen in a
variety of medical settings and are often a
source of frustration because of their
incessant visits and resistance to reassur-
ance. Despite their relatively small num-
bers they are liable to consume a dispro-
portionately large share of the available
health resources because of excessive con-
sultations, special investigations and treat-
ment. This imposes an important respon-
sibility on doctors, particularly at primar y
care level, to identify and manage t h e s e
p atients appropri ately and timeously.
These are a fascinating group of condi-
tions that have recently emerged from a
period of relative disregard and neglect.
Interest has been aroused by research
findings in fields such as psychoneuroim-
munology, invoking a reconceptualisation
of conventional notions of health and dis-
ease, and a re-exploration of the mind-
body divide.
Historically, the status of these disorders
has often been controversial and illustrates
the powerful role of historical epoch and
culture in shaping the expression of emo-
tional distress. The current preoccupation
with health and the perfect appearance,
and the arrival of indeterminate condi-
tions such as chronic fatigue syndrome
and Gulf War syndrome, illustrate this.
The differentiation between physical ill-
ness and psychogenic symptoms, while
being problematic philosophically because
of its inherently dualistic orientation,
remains limited by currently available sci-
entific evidence. The somatoform disor-
ders have achieved a degree of legitimacy
by their inclusion in current psychiatric
disease classifications. This is not without
problems, demonstrated by the unfortu-
nate attachment of stigma and other social
disadvantages that psychiatric diagnoses
often attract (somatisers are not very pop-
ular people!).
CLASSIFICATION
The fourth edition of the Diagnostic and
Statistical Manual of Mental Disorders
(DSM-IV), the American Psychiatric
Association’s catalogue of mental disor-





• body dysmorphic disorder
• pain disorder.
There are also two residual categories,
namely undifferentiated somatoform dis-
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order and somatoform disorder not
otherwise specified, to accommo-
date symptoms that do not meet
the criteria for the specific somato-
form disorder diagnoses.
Somatisation disorder is charac-
terised by a variety of symptoms in
multiple organ systems, usually a
combination of pain, gastrointesti-
nal, sexual and pseudoneurological
symptoms. It differs from the
other somatoform disorders by this
multiplicity of complaints and the
multiple organ systems involved.
The disorder is chronic, with onset
before 30 years of age, and is asso-
ciated with significant psychologi-
cal distress, psychosocial dysfunc-
tion and excessive help-seeking
behaviour. Patients often have
poor social support and generally
require social grants. There is a
strong association with co-morbid
psychiatric problems including
depression, cluster-B personality
disorder (histrionic and border-
line), and eating disorders. There
may be a history of childhood sex-
ual abuse and complex post-trau-
matic stress disorder (PTSD). The
management of these patients is
often complicated by difficulties in
the doctor-patient relationship,
repeated acting-out behaviours
such as parasuicide and deliberate
self-harm, and substance abuse.
Conversion disorder is defined
by the presence of one or more
neurological symptoms (e.g. paral-
ysis, blindness, seizures, or numb-
ness) that cannot be accounted for
by a diagnosable neurological or
medical disorder. Physical exami-
nation may reveal unanatomical
physical signs, and special investi-
gation results are usually negative.
The relationship between the phys-
ical symptom and the underlying
psychological conflict may be strik-
ingly clear (e.g. paralysis in a sol-
dier facing battle). Conversion
symptoms, which are significantly
more common in women than
men, may be a manifestation of
childhood sexual abuse. They may
also be the presenting problem in
the index patient in a dysfunctional
family, often distracting the family
and the treating doctor from more
significant problems such as
domestic violence, sexual abuse or
alcoholism. It is important to
remember that conversion symp-
toms can occur in patients with
established neurological disease
(i.e. pseudoseizures in an epilep-
tic). Similarly, a significant num-
ber of patients diagnosed with con-
version symptoms will eventually
receive an actual disease diagnosis.
Bias towards women within med-
ical systems and towards patients
from diverse cultural or deprived
backgrounds needs to be guarded
against to prevent premature diag-
nosis of conversion disorders in the
presence of actual disease.
Hypochondriasis, the common-
est of the somatoform disorders, is
defined by the presence of a pre-
occupation with fears of having a
serious disease based upon the
misinterpretation of one or more
physical symptoms. Hypochon-
driacs are less concerned with their
symptoms per se than they are with
what their symptoms signify. They
often display an obsessive preoccu-
pation with their bodies and har-
bour the conviction that they are
afflicted with a serious disease.
They visit their doctors repeatedly,
present their complaints in a
detailed and ruminative manner
(in contrast to the histrionic style
seen in somatisation disorder), and
defy the reassurances offered by
negative examinations and special
investigations. Men and women
are affected in equal numbers and
there may be a strong family histo-
ry of hypochondriasis. Patients’ ill-
ness concerns result in significant
distress to themselves, their loved
ones, and (not least) their treating
doctors.
Body dysmorphic disorder is
characterised by a preoccupation
with an imagined anatomical
defect (e.g. a large nose) or an
exaggerated distortion of a minor
defect in physical appearance (e.g.
mild acne). Despite its apparent
triviality, the condition may be
severely stressful for patients, who
may be virtually incapacitated by
social avoidance and emotional dis-
tress. Cultural shaping may play a
significant role in the generation of
these concerns by the high premi-
um placed on physical appearance
in some societies. Patients are
inclined to avoid mirrors or scruti-
ny through social exchanges and
will often procure repeated plastic
surgical procedures. There seems
to be a correlation with obsessive-
compulsive disorder in terms of
some of the clinical features and
the underlying biological substrate,
which is supported by a shared
response to certain anti-obsessional
psychotropic drugs.
Pain disorder is similar to a con-
version disorder in which pain is
the presenting complaint. The
underlying cause must be at least
partially psychogenic, and the con-
dition should be accompanied by a
degree of emotional and functional
impairment. There may be an
associated physical condition, but
the pain is out of proportion to its
extent or severity. Pain disorder is
diagnosed twice as frequently in
women as in men, and there may
be a positive family history. Many
It may be necessary
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chronic pain specialists find the
notion of somatoform pain prob-
lematical. There are inherent diffi -
culties in trying to discriminate
physically based pain from psy-
chogenic pain, and the somatising
aspect of the diagnosis may lead to
a tendency to underestimate the
patient’s subjective pain experi-
ence. The stigmatising effect of
acquiring a psychiatric diagnosis
may also be uncomfortable for
patients.
MANAGEMENT
The management of the somato-
form disorders is widely regarded
as complex and challenging, and is
often shrouded in a pall of pes-
simism and despair. This view is
justified to some extent by the fre-
quent chronicity and tenacity of
somatoform symptoms. However,
this should not obscure the fact
that some fairly straightforward
interventions can offer dramatic
results, particularly if offered
timeously, before the symptoms
and accompanying pathological ill-
ness behaviours become
entrenched. Many of these inter-
ventions can be (and often have to
be) administered at the primary
care level. Specialist assessment
may be necessary in complex
cases, especially in the presence of
co-morbid psychiatric disorders or
substance abuse.
It is useful to organise the assess-
ment and management approach
around a series of discrete steps.
The initial evaluation of somatic
symptoms should always be direct-
ed at excluding an underlying
physical illness . It may be diffi-
cult to determine how far to pro-
ceed in the face of negative results,
especially when patients refuse to
be reassured by these. The nag-
ging possibility that an occult med-
ical condition could emerge later
may engender doubt and anxiety.
When it becomes apparent that the
physical symptoms are psychogenic
in origin, a complete psychiatric
assessment is required. A specific
somatoform disorder diagnosis is
made according to a standard sys-
tem of classification, for example,
the DSM-IV, including an assess-
ment of the duration, severity and
psychosocial impact of the symp-
toms. Somatic symptoms may
accompany a range of psychiatric
disorders, including depression,
anxiety disorders, schizophrenia,
and substance use disorders (which
masquerade as vague physical
symptoms for which patients
repeatedly seek medical attention).
The identification of co-morbid
psychiatric conditions may have
very important treatment and
prognostic implications.
A crucial next step is the formula-
tion of a biopsychosocial under -
standing of the patient and his/her
symptoms. This would address
matters such as familial and tem-
peramental vulnerabilities; the
symbolic meaning the patient
ascribes to the symptoms and how
this connects with formative and
current life experiences; the influ-
ence of stressful life circumstances;
the role of learning, especially as it
applies to the reinforcement of
pathological illness behaviour; and
the broader overarching influence
of the social and cultural context.
These assessments will determine
the choice of a definitive trea t-
ment strategy for the individual
patient.
A central feature of that definitive
treatment strategy is the doctor-
patient relationship . It has been
demonstrated repeatedly that the
most helpful intervention for many
patients with somatoform disorder s
is a stable, ongoing relationship
with a caring, reassuring and sup-
portive doctor who can empatheti-
cally understand and validate their
physical and emotional distress.
The ideal doctor would have great
skills not only at mediating
patients’ inner conflicts, but also in
dealing with his ‘own stuff’. He
should be undogmatic, open-mind-
ed and able to cope with uncer-
tainty when confronted with a con-
dition where the physical and psy-
chological bases are unclear.
Conflicts between empathy and
apathy, underinvolvement and
overinvolvement, undertreatment
and overtreatment, and a range of
other emotional responses includ-
ing frustration, anger, resentment
and despair may need to be man-
aged appropriately, for example in
doctor support groups. Patients
often make unreasonable demands
with regard to the frequency and
extent of treatment. It may be
necessary to clarify the limits of the
interventions on offer, and
appointments may have to be
scheduled strictly.
Because of the invariable impact
on social functioning, it may be
useful to offer couple or family
interventions, and the assistance of
a social worker and other members
of a multidisciplinary team (i.e.
psychologists and occupational
therapists) could prove helpful.
Psychopharmacological treatments
are used most commonly in
patients who have co-morbid psy-
chiatric conditions, and the soma-
toform symptoms may resolve with
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successful treatment. The selective
serotonin reuptake inhibitors
(SSRIs) have shown some success,
especially in somatoform disorders
characterised by obsessional fea-
tures, such as hypochondriasis and
body dysmorphic disorder.
Cognitive behaviour therapy,
which can be delivered in individ-
ual or group settings, has also
shown a range of benefits with
regard to symptom reduction and
enhancing overall sense of well-
being.
It is not unusual for legal and ethi-
cal issues to arise in the manage-
ment of these patients, given the
range of difficulties already men-
tioned. The legal matters usually
revolve around confidentiality and
access to patient information.
Ethical issues may arise in the con-
text of emotional conflict between
the doctor and the patient or by
desperation and frustration often
experienced by both. This may
take many forms, for example the
temptation to administer treatment
without full disclosure of its pur-
pose or mode of action (i.e. a
placebo), deliberately overtreating
a trivial condition and exposing the
patient to iatrogenic hazards, and
colluding in other ways with
patients’ pathological illness behav-
iours for perverse gain. These are
common pitfalls that ought to be
guarded against by constant vigi-
lance and the highest ethical stan-
dards at all times.
CONCLUSION
Patients who somatise their emo-
tional difficulties are seen in many
medical settings. They are relatively
small in number, but can potential-
ly consume a large portion of the
available health resources. They
resist reassurance and are often in
conflict with their doctors, with
invariable professional, ethical and
legal implications. Prompt manage-
ment promises the best outcome.
This imposes an important respon-
sibility on primary care practition-
ers to screen and manage these
patients appropriately.
Conceptually, these disorders oper-
ate in the exciting and burgeoning
field of psychosomatic medicine in
which fascinating research findings
are emerging.They invite a re-
exploration of the boundaries of
mind-body medicine, and a recon-
sideration of the social and cultural
determinants of health and disease.
IN A NUTSHELL
Somatomform disorders are char-
acterised by physical symptoms
in the absence of a diagnosable
medical condition.
Somatoform disorders are classi-
fied in the DSM-IV into five specif-
ic types: somatisation disorder,
conversion disorder, hypochon-
driasis, body dysmorphic disor-
der, pain disorder.
Somatisation disorder exhibits a
combination of multiple organ
symptoms, involving pain, gas-
trointestinal, sexual and
pseudoneurological symptoms.
Conversion disorder is defined by
the presence of one or more
neurological symptoms, e.g.
blindness, paralysis, seizures or
numbness.
Hypochondriasis is defined by the
presence of a preoccupation with
fears of having a serious disease.
Physical symptoms are misinter-
preted.
Body dysmorphic disorder is
characterised by a preoccupation
with an imagined anatomical
defect such as a large nose, or an
exaggeration of a minor appear-
ance defect.
Pain disorder is similar to conver-
sion disorder, with pain being the
presenting complaint.
Management should be prompt,
with a thorough assessment, ini -
tially directed at excluding an
underlying physical illness.
A complete psychiatric assess-
ment may be required, and iden-
tification of co-morbid psychiatric




may suffer or be severely
strained.
Psychopharmacological treat-
ments and/or cognitive behaviour
therapy may be indicated.
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